by Usha Govindarajulu | Jun 23, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
June 22, 2022 In a recent article in News Medical Lifesciences, they have discussed a recent research paper published as an accepted manuscript in the Clinical Infectious Diseases journal in which the scientists analyzed the population immunity against pre-Omicron and...
by Usha Govindarajulu | Apr 13, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
Issues in COVID-19 research and statistical analyses (Part XVVVIII) April 13, 2022 In one of the latest Scientific American article, “What We Know about Omicron’s BA.2 Variant So Far”, the article summarizes some of the latest research about this new COVID-19 variant,...
by Usha Govindarajulu | Mar 30, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
March 30, 2022 Latest research published in the Lancet shows diabetes onset was higher for those with post-acute sequelae or long-haul COVID-19 however these may be preliminary results. The results came from a cohort study which used databases from the United States...
by Usha Govindarajulu | Mar 16, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
March 15, 2022 In a recent article in The Scientist than appeared back in January, they mentioned using several pre-print articles which are cited for this article. In one of the pre-print articles by Adamson et al published on March 5 about a very recent small study...
by Usha Govindarajulu | Jan 20, 2022 | Biostatistics, Blog, COVID-19, Professor, Usha Govindarajulu
January 18, 2022 A recent article in the New England Journal of Medicine (NEJM) presents results from a large cohort study from New York State on COVID-19 vaccine effectiveness. They used data for 8,690,825 adults in New York State to assess the effectiveness of the...
